ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Press
August 6, 2024
09 Jan 2018

DAN-NICADII-studie startas för att bredda tillämpningen av det icke-invasiva Acarix CADScor®System för snabb uteslutning av kranskärlssjukdom

Pressmeddelande Malmö, 9 januari, 2018 DAN-NICADII-studie startas för att bredda tillämpningen av det icke-invasiva Acarix CADScor®Syst...
Continue reading
author-avatar acarix
Corporate Information, IR, News, Other Corporate Information, Swedish
November 18, 2024
09 Jan 2018

DAN-NICADII-studie startas för att bredda tillämpningen av det icke-invasiva Acarix CADScor®System för snabb uteslutning av kranskärlssjukdom

PressmeddelandeMalmö, 9 januari, 2018DAN-NICADII-studie startas för att bredda tillämpningen av det icke-invasiva Acarix...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
09 Jan 2018

DAN-NICADII study to expand the applicability of the non-invasive Acarix CADScor®System for rapid ruling out Coronary Artery Disease

Press releaseMalmö, January 9, 2018DAN-NICADII study to expand the applicability of the non-invasive Acarix CADScor®System for...
Continue reading
author-avatar acarix
Press
August 6, 2024
09 Jan 2018

DAN-NICADII study to expand the applicability of the non-invasive Acarix CADScor®System for rapid ruling out Coronary Artery Disease

Press release Malmö, January 9, 2018 DAN-NICADII study to expand the applicability of the non-invasive Acarix CADScor®System for rapid ...
Continue reading
author-avatar acarix
Corporate Information, IR, News, Other Corporate Information, Swedish
November 18, 2024
29 Nov 2017

Nya data publicerade i den ledande tidskriften Heart visar att det icke-invasiva Acarix CADScor®System på ett säkert sätt utesluter CAD på några minuter

PressmeddelandeMalmö, 29. november, 2017Nya data publicerade i den ledande tidskriften Heart visar att det icke-invasiva Acarix CA...
Continue reading
author-avatar acarix
Press
August 6, 2024
29 Nov 2017

Nya data publicerade i den ledande tidskriften Heart visar att det icke-invasiva Acarix CADScor®System på ett säkert sätt utesluter CAD på några minuter

Pressmeddelande Malmö, 29. november, 2017 Nya data publicerade i den ledande tidskriften Heart visar att det icke-invasiva Acarix CADS...
Continue reading
author-avatar acarix
Press
August 6, 2024
29 Nov 2017

New data published in leading journal Heart proves non-invasive Acarix CADScor®System safely rules out CAD in minutes

Press release Malmö, November 29, 2017 New data published in leading journal Heart proves non-invasive Acarix CADScor®System safely r...
Continue reading
author-avatar acarix
Corporate Information, English, IR, News, Other Corporate Information
November 18, 2024
29 Nov 2017

New data published in leading journal Heart proves non-invasive Acarix CADScor®System safely rules out CAD in minutes

Press releaseMalmö, November 29, 2017New data published in leading journal Heart proves non-invasive Acarix CADScor®System saf...
Continue reading
author-avatar acarix
Interim, IR, MAR, News, Q3, Regulatory, Report, Swedish
November 18, 2024
14 Nov 2017

Delårsrapport, januari – september 2017: CADScor®System lanserat på ytterligare viktiga marknader

PressmeddelandeMalmö, 14 november 2017Delårsrapport, januari - september 2017: CADScor®System lanserat på ytterlig...
Continue reading
author-avatar acarix
Press
August 6, 2024
14 Nov 2017

Delårsrapport, januari – september 2017: CADScor®System lanserat på ytterligare viktiga marknader

Pressmeddelande Malmö, 14 november 2017 Delårsrapport, januari - september 2017: CADScor®System lanserat på ytterligare viktiga marknad...
Continue reading
author-avatar acarix
English, Interim, IR, MAR, News, Q3, Regulatory, Report
November 18, 2024
14 Nov 2017

Interim report, January – September 2017: CADScor®System launched in additional key markets

Press releaseMalmö, November 14, 2017Interim report, January - September 2017: CADScor®System launched in additional key marke...
Continue reading
author-avatar acarix
Press
August 6, 2024
14 Nov 2017

Interim report, January – September 2017: CADScor®System launched in additional key markets

Press release Malmö, November 14, 2017 Interim report, January - September 2017: CADScor®System launched in additional key markets &#...
Continue reading
  • «
  • ‹
  • 74
  • 75
  • 76
  • 77
  • 78
  • ›
  • »

Acarix AB

Jungmansgatan 12
211 19 Malmö
SE
info@acarix.com

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V6

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.